Weight Loss clinical trials
The registry lists 1,818 studies for Weight Loss across more than 10 countries. 296 are recruiting or about to start. 299 of them are mainly about Weight Loss (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-16. Counting its narrower condition Cachexia too: 2,118 studies, 363 open.
ClinicalTrials.gov finds 3,512 studies for Weight Loss. How that becomes 1,818 here
This page counts the studies the registry files under Weight Loss, and those it files under no condition that list Weight Lossthemselves. Each study its search finds is placed by how the registry filed it and by the conditions it lists. ClinicalTrials.gov counts as of Nov 16, 2026. How condition pages count
- 3,512Found by its condition searchIt reads the conditions a study lists and their synonyms, and also titles and keywords.
- −272Filed under a narrower condition, counted on its own pageCachexia 272
- −22List Weight Loss as a condition, but the registry did not file them under itMost often written as “Weight Loss Maintenance” (3), “Weight Loss Trial” (3), and “Inadequate Initial Weight Loss” (2). The registry filed them under other conditions only, most often Obesity (12) and Overweight (5).
- −1,400Match it another way1,138 name it in the title, 94 in a keyword, and 168 by a synonym or other text the search reads.
- 1,818The count on this page12 of them list Weight Loss in their own words; the registry filed them under no condition.
Get an email when these change. Save the Weight Loss studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your alerts, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your alerts. Stop any time.
Status
Who runs them
The Miriam Hospital (29) · Wake Forest University Health Sciences (28) · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (22) · University of Pittsburgh (22) · University of California, San Diego (21) · University of Alabama at Birmingham (21) · University of Colorado, Denver (20) · University of North Carolina, Chapel Hill (20)
What is being tested here
Drugs under test in Weight Loss studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted
| Drug | Open | Phase 3 | All |
|---|---|---|---|
| Semaglutide | 15 | 4 | 24 |
| Tirzepatide | 9 | 2 | 10 |
| VK2735 | 3 | 4 | 8 |
| Berobenatide | 3 | 3 | 4 |
| Metformin | 2 | 3 | 9 |
| Phentermine | 2 | 0 | 7 |
| Ponsegromab | 2 | 1 | 5 |
| Mazdutide | 2 | 0 | 3 |
| Efsubaglutide alfa | 2 | 0 | 2 |
| Liraglutide | 1 | 5 | 16 |
Drug classes tested here GLP-1 receptor agonists 24 open · Stimulants 2 open · Antipsychotics 1 open · SGLT2 inhibitors 9 · Antiemetics 3
Coming up
Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.
The 10 nearest, phase 3 first
- Dec 2026The Effect of Exercise and Tirzepatide on Weight and Health Outcomes (EXER-MED) · Phase 3 · University of Virginia
- Dec 2026Tailored Exercise Training Study Among Adults With HFpEF · Phase 3 · University of Texas Southwestern Medical Center
- Mar 2027Effect of Metformin Use on Weight Loss in Obese, Non-diabetic People (MOWRI) · Phase 3 · University Of Nigeria Teaching Hospital
- May 2027Megestrol Acetate in Improving Neoadjuvant Chemotherapy-Related Weight Loss in Locally Advanced CRC · Phase 3 · Sixth Affiliated Hospital, Sun Yat-sen University
- Jun 2027Evaluation of the Efficacy and Safety of Tirzepatide, a Dual GLP-1/GIP Agonist, on Functional Capacity in Reduced Ejection Fraction Heart Failure Patients With Obesity · Phase 3 · Shahid Beheshti University of Medical Sciences
- Jul 2027VK2735 for Weight Management Type 2 Diabetes Phase 3 (VANQUISH 2) · Phase 3 · Viking Therapeutics, Inc.
- Jul 2027VK2735 for Weight Management Phase 3 · Phase 3 · Viking Therapeutics, Inc.
- Sep 2027Prophylactic Nanocrystalline Megestrol Acetate Versus Placebo for Chemoradiotherapy-Related Anorexia in Nasopharyngeal Carcinoma · Phase 3 · Sun Yat-sen University
- Nov 2026Weight Loss and Endocrine Disrupting Chemicals (EDCs): Lifestyle Interventions to Lose Weight and Reduce EDC Exposure in Individuals With Overweight/Obesity · Million Marker Wellness, Inc.
- Nov 2026Effects of Inulin on Cardiometabolic Risk Factors in Individuals Using Glucagon-like Peptide-1 Receptor Agonists (GLP-1 RA ) Medications for Weight Loss · Huazhong University of Science and Technology
Who these studies take
Of the 199 Weight Loss studies recruiting now, 73 (37%) set no upper age limit and 109 (55%) stop at 75 or younger. 21 (11%) take children under 18. 11 (6%) are for women only and 4 (2%) for men only; 57 (29%) take healthy volunteers.
| Age | Women | Men |
|---|---|---|
| 10 | 9 (5%) | 7 (4%) |
| 18 | 150 (75%) | 145 (73%) |
| 30 | 171 (86%) | 165 (83%) |
| 40 | 175 (88%) | 169 (85%) |
| 50 | 174 (87%) | 167 (84%) |
| 65 | 151 (76%) | 144 (72%) |
| 75 | 101 (51%) | 95 (48%) |
| 85 | 82 (41%) | 76 (38%) |
Across all 1,818 studies, recruiting or not: 64% stop at 75 or younger and 48% at 65; 8% take children; 13% are for women only and 3% for men only; 44% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.
How long Weight Loss studies take
Of 45 phase 4 interventional studies under Weight Loss, half reached primary completion within 29 months of starting, counting those still running.
| Start to primary completion | Every sponsor | Industry | Non-industry |
|---|---|---|---|
| Phase 1 | 15 mo8–25 · 24 studies | — | — |
| Phase 2 | 32 mo11–56 · 44 studies | — | — |
| Phase 3 | 24 mo14–28 · 23 studies | — | — |
| Phase 4 | 29 mo19–46 · 45 studies | — | 33 mo25–51 · 40 studies |
| Interventional, no phase | 24 mo11–43 · 730 studies | 10 mo6–21 · 59 studies | 25 mo13–45 · 671 studies |
| Observational | 32 mo16–99 · 93 studies | — | 37 mo17–99 · 86 studies |
Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out
What changed recently
From the registry's own updates since Oct 18, 2026.
Started recruiting6
- GLP-1 Medication & Behavioral Health Programs on Weight & Metabolic Outcomes: FLOURISH and THRIVE Prospective Cohort StudyNov 16, 2026NCT07588984
- Oral VK2735 for Weight Management Phase 3 (SUNRISE 1)Nov 16, 2026NCT07868835
- Oral VK2735 for Weight Management in Adults With Type 2 Diabetes Mellitus Phase 3 (SUNRISE 2)Nov 16, 2026NCT07868939
- Efficacy and Safety of Olatorepatide Versus Placebo in Adults With Moderate to Severe Hidradenitis Suppurativa Living With Overweight or ObesityNov 10, 2026NCT07830329
- A Study to Learn About the Study Medicine Called PF-08653944 Taken Once-Monthly Compared to Placebo in Chinese Adults With Overweight or ObesityNov 6, 2026NCT07874633
Show 1 moreShow fewer
- Translational Health Research Into Vascular and Neurocognitive Effects of Weight LossOct 26, 2026NCT07592546
Results posted3
- Pragmatic Research in Healthcare Settings to Improve Diabetes and Obesity Prevention and Care for Our ProgramNov 12, 2026NCT04420936
- Spark: Finding the Optimal Tracking Strategy for Weight Loss in a Digital Health InterventionNov 4, 2026NCT05249465
- Aromatase Inhibitors and Weight Loss in Severely Obese Men With HypogonadismOct 19, 2026NCT03490513
Newly registered17
- Effects of a Gut-Active Peptide That Stimulates GLP-1 Release on Appetite and Satiety in Healthy Adults With OverweightNov 13, 2026NCT07936838
- The Purpose of This Study is to Learn About the Safety and Effectiveness of Berobenatide in Women With Urine Leakage and With Obesity or OverweightNov 12, 2026NCT07932925
- Exercise and Protein to Reduce Muscle Loss During GLP-1-Based Treatment in Type 2 DiabetesNov 9, 2026NCT07926152
- Intermittent Fasting and Anthropometric ParametersNov 3, 2026NCT07912255
- The Effect of Liraglutide on Body Weight, Body Composition, Ectopic Lipid Accumulation and Insulin Sensitivity in Subjects With Overweight or Obesity Without DiabetesNov 3, 2026NCT07913685
Show 12 moreShow fewer
- Semaglutide for Weight Management During Hormone Therapy for Early Breast CancerNov 2, 2026NCT07909889
- Brain and Obesity Longitudinal Development: Neurobiological Mechanisms of Semaglutide Treatment of Adolescent ObesityNov 2, 2026NCT07911046
- Gut-Liver-Muscle Axis in Cancer CachexiaNov 2, 2026NCT07911150
- Mechanisms of Weight Loss: Tirzepatide vs SemaglutideOct 28, 2026NCT07900074
- Sustaining Health After an Intensive Weight-loss Pro-grammeOct 28, 2026NCT07900178
- Two-Year Weight Loss With GLP-1 Medications Compared With Sleeve Gastrectomy in Adults With ObesityOct 28, 2026NCT07901777
- Investigating the Effects of 24 Hour LEAP2 Infusion in Individuals With Overweight and ObesityOct 27, 2026NCT07897383
- Testing Health-Related Interventions: Voices of Equity Needed to Overcome Weight-bias in Obesity-Cancer CareOct 27, 2026NCT07897890
- Master Protocol for the Study of Rilogrotug for the Treatment of Weight Loss and Anorexia in Patients With Cancer Cachexia and mCRC or mNSCLCOct 22, 2026NCT07888075
- A Study to Investigate the Effect of LY4086940 Versus Placebo in Participants With Obesity or Overweight and Without Type 2 DiabetesOct 22, 2026NCT07890376
- 15-years Outcomes of Sleeve Gastrectomy on Weight LossOct 20, 2026NCT07883018
- Weight Loss and Comorbidity Outcomes After Revisional Bariatric SurgeryOct 19, 2026NCT07880691
Studies
Recruiting first, then most recently updated. Showing 50 of 1,818. Browse all 1,818 → or search them.
- Oral VK2735 for Weight Management in Adults With Type 2 Diabetes Mellitus Phase 3 (SUNRISE 2)RecruitingNCT07868939Phase 31 country
- Diet Order Effects of Low Fat vs. Low Carb Diets on Body Fat ChangeRecruitingNCT06325722Not applicable1 country
- Oral VK2735 for Weight Management Phase 3 (SUNRISE 1)RecruitingNCT07868835Phase 31 country
- GLP-1 Medication & Behavioral Health Programs on Weight & Metabolic Outcomes: FLOURISH and THRIVE Prospective Cohort StudyRecruitingNCT075889841 country
- WISE-2B Brain Study (Weight Loss Intervention Surgical Effects on Brain Function)RecruitingNCT06861790Not applicable1 country
- Effects of a Gut-Active Peptide That Stimulates GLP-1 Release on Appetite and Satiety in Healthy Adults With OverweightNot yet recruitingNCT07936838Not applicable1 country
- PRE-Pregnancy Weight Loss And the Reducing Effect on CHILDhood Overweight - AarhusRecruitingNCT05798494Not applicable1 country
- Effect of Retatrutide Versus Placebo in Participants Who Have Obesity or Are OverweightRecruitingNCT07467447Phase 21 country
- The Purpose of This Study is to Learn About the Safety and Effectiveness of Berobenatide in Women With Urine Leakage and With Obesity or OverweightNot yet recruitingNCT07932925Phase 3
- Weight Management in Obese Cancer Patients During Curative Active TreatmentRecruitingNCT07058207Not applicable1 country
- Efficacy and Safety of Olatorepatide Versus Placebo in Adults With Moderate to Severe Hidradenitis Suppurativa Living With Overweight or ObesityRecruitingNCT07830329Phase 21 country
- Family COMIDA (Consumo de Opciones Más Ideales De Alimentos) (Eating More Ideal Food Options)RecruitingNCT07144800Not applicable1 country
- A Study to Investigate the Efficacy and Safety of Elecoglipron in Asian Participants With Obesity or Overweight With or Without Type 2 Diabetes MellitusRecruitingNCT07775404Phase 35 countries
- Exercise and Protein to Reduce Muscle Loss During GLP-1-Based Treatment in Type 2 DiabetesNot yet recruitingNCT07926152Not applicable1 country
- Two-Year Weight Loss With GLP-1 Medications Compared With Sleeve Gastrectomy in Adults With ObesityRecruitingNCT079017771 country
- A Study to Learn About the Study Medicine Called PF-08653944 Taken Once-Monthly Compared to Placebo in Chinese Adults With Overweight or ObesityRecruitingNCT07874633Phase 31 country
- Metabolic Health, Bones and Nuts During Weight Loss in AdultsRecruitingNCT06949280Not applicable1 country
- Gut-Liver-Muscle Axis in Cancer CachexiaNot yet recruitingNCT07911150Not applicable1 country
- A Study to Learn About the Study Medicine Called PF-08653944 Taken Once-Weekly Compared to Placebo in Chinese Adults With Overweight or ObesityRecruitingNCT07792954Phase 31 country
- A Study to Investigate the Effect of LY4086940 Versus Placebo in Participants With Obesity or Overweight and Without Type 2 DiabetesNot yet recruitingNCT07890376Phase 22 countries
- Visugromab in Cachexia International TrialRecruitingNCT07112196Phase 2/314 countries
- Semaglutide for Weight Management During Hormone Therapy for Early Breast CancerNot yet recruitingNCT07909889Phase 21 country
- Brain and Obesity Longitudinal Development: Neurobiological Mechanisms of Semaglutide Treatment of Adolescent ObesityNot yet recruitingNCT079110461 country
- Time Restricted Eating for WeIght LoSs MainTenance-2RecruitingNCT07190170Not applicable1 country
- Tirzepatide Versus Positive Airway Pressure for the Treatment of Obstructive Sleep ApnoeaNot yet recruitingNCT07846865Phase 2/31 country
- Sustaining Health After an Intensive Weight-loss Pro-grammeEnrolling by invitationNCT079001781 country
- Master Protocol for the Study of Rilogrotug for the Treatment of Weight Loss and Anorexia in Patients With Cancer Cachexia and mCRC or mNSCLCNot yet recruitingNCT07888075Phase 2/3
- Mechanisms of Weight Loss: Tirzepatide vs SemaglutideRecruitingNCT07900074Phase 41 country
- OverStitch NXT Endoscopic Suture SystemRecruitingNCT07276815Not applicable1 country
- Investigating the Effects of 24 Hour LEAP2 Infusion in Individuals With Overweight and ObesityNot yet recruitingNCT07897383Phase 1/2
- Orbera365 Intragastric Balloon System (Abbreviated as'Orbera365')RecruitingNCT07195708Not applicable1 country
- iWAIST Trial: ERCG (Endoscopic Radial Compression Gastroplasty) +Optimized Lifestyle Intervention (OLI) vs Sham + OLI for Weight LossRecruitingNCT07237750Not applicable1 country
- Translational Health Research Into Vascular and Neurocognitive Effects of Weight LossRecruitingNCT07592546Phase 41 country
- The Sleep2BWell TrialRecruitingNCT06565104Not applicable1 country
- Optimizing Portal Hypertension With TIPS and Interval Metabolic Surgery for Advanced Liver DiseaseRecruitingNCT07058155Phase 41 country
- Diabetes Prevention Through Genetics, Familial History and Behavior ChangeNot yet recruitingNCT07815236Phase 2/3
- Small Intestinal Bacterial Overgrowth (SIBO) in Pancreatic Adenocarcinoma (PDAC)RecruitingNCT069881501 country
- Resistance Training to Prevent Muscle Loss During Treatment With TirzepatideRecruitingNCT07777575Phase 41 country
- 15-years Outcomes of Sleeve Gastrectomy on Weight LossRecruitingNCT078830181 country
- Prophylactic Nanocrystalline Megestrol Acetate Versus Placebo for Chemoradiotherapy-Related Anorexia in Nasopharyngeal CarcinomaRecruitingNCT07796789Phase 31 country
- A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and FatigueRecruitingNCT06989437Phase 2/321 countries
- Randomized Study on Transoral Outlet Reduction and Lifestyle Changes for Weight Regain After Gastric BypassRecruitingNCT07015424Not applicable1 country
- Benefits of Nutritional Supplement in Cancer CareNot yet recruitingNCT07869290Not applicable
- Trial of Innovative Fat-loss Focused Approaches in Patients With Class I Obesity: a Comparative StudyRecruitingNCT07866183Not applicable1 country
- Weight Loss Composition and Metabolic Adaptation During Hypocaloric DietingNot yet recruitingNCT07627256Not applicable
- Phentermine's Impact on Treatment in TeensRecruitingNCT07282340Phase 21 country
- Metabolism and Nutrition in MNDNot yet recruitingNCT078517141 country
- A Novel Intervention for Weight Loss in Young AdultsRecruitingNCT06230744Not applicable1 country
- Semaglutide, Weight Loss, and LNG-IUD for Conservative Treatment of Endometrial Atypical Hyperplasia and Grade 1 Endometrial CancerNot yet recruitingNCT07820358Phase 21 country
- Precision Nutrition for Obesity and Prediabetes Prevention in Under-supported CommunitiesNot yet recruitingNCT07850531Not applicable1 country